Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatopulmonary syndrome.

Miguel R Arguedas1, Michael B Fallon

  • 1Department of Medicine, Division of Gastroenterology/Hepatology, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA.

Clinics in Liver Disease
|October 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial Disparities in Clinical and Cardiometabolic Outcomes Among Patients with Alcohol-Associated Liver Disease.

Digestive diseases and sciences·2026
Same author

Alveolar Type 2 Cell Dysfunction Is Associated with Bile Acid Alterations in Experimental Hepatopulmonary Syndrome.

American journal of respiratory cell and molecular biology·2026
Same author

The Importance of Liver-Lung Communication in Pulmonary Vascular Diseases.

Comprehensive Physiology·2026
Same author

Disparities in Liver Transplantation Among Native Americans and Hispanic Individuals: Insights from a Southwest Region Center in the United States of America.

Journal of clinical medicine·2026
Same author

Liver transplantation for hepatopulmonary syndrome: A systematic review and meta-analysis.

JHEP reports : innovation in hepatology·2026
Same author

Pre-TIPS Diastolic Dysfunction as a Predictor of Post-TIPS Outcomes in Patients With Cirrhosis.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Hepatopulmonary syndrome, a vascular complication of cirrhosis, impairs oxygenation and increases mortality in liver disease patients. Further research into its pathophysiology may yield new medical treatments beyond liver transplantation.

Area of Science:

  • Vascular complications of liver disease
  • Pulmonary medicine
  • Transplantation medicine

Background:

  • Hepatopulmonary syndrome (HPS) is a significant vascular complication in cirrhosis.
  • It involves microvascular dilatation, impairing arterial oxygenation.
  • HPS affects up to 20% of liver transplant candidates and is linked to higher mortality.

Purpose of the Study:

  • To review the pathophysiology of hepatopulmonary syndrome.
  • To highlight the limitations of current treatments.
  • To suggest avenues for developing novel medical therapies.

Main Methods:

  • Review of existing literature on hepatopulmonary syndrome.
  • Analysis of pathophysiologic insights from experimental models.
  • Discussion of current treatment strategies and outcomes.

Related Experiment Videos

Main Results:

  • Hepatopulmonary syndrome is a common and serious complication of cirrhosis.
  • Current medical therapies for HPS are not clearly effective.
  • Liver transplantation remains the only established treatment for HPS.

Conclusions:

  • Understanding the pathophysiology of HPS is crucial for developing new treatments.
  • Experimental models offer potential insights for novel therapeutic strategies.
  • Further research may lead to effective medical interventions for hepatopulmonary syndrome.